U Star Biochemical Technologies, Inc.
PrivateLast Round
Series E
Extension
Nov 30, 2021
Total Funding Raised
$88.95M
Company Overview
U Star Biochemical Technologies, Inc. operates in Healthcare & Life Sciences and is based in Taichung City. Its latest recorded funding round was a Series E Extension round in November 2021.
U Star Biochemical Technologies, Inc. is a biotechnology company that specializes in the development of natural functional products, medical-grade skincare, and health supplements.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, D2C Brands, Home & Lifestyle
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
U Star Biochemical Technologies, Inc. Comparables
Compare U Star Biochemical Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Grape King Bio Ltd | 73% | |
| GenMont Biotech Inc. | 66% | |
| Microbio Co Ltd | 63% |
For institutional investors. Book with your work email.
U Star Biochemical Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E Extension | Nov 30, 2021 | ||||
| Series E | Feb 19, 2021 | ||||
| Series D | Jun 27, 2018 | ||||
| Series C | Oct 1, 2014 | ||||
| Series B | May 16, 2012 |
For institutional investors. Book with your work email.
U Star Biochemical Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series E Extension, Series E |
| Stop TB Partnership | Grant |
| CITIC Private Equity Funds Management | Series E Extension |
| C Capital | Series E |
| 兼固资本 | Series E |
| Unitaid | Grant |
| SAIF Partners China | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 30, 2021
$47M round led by CITIC Private Equity Funds Management.
- Jun 27, 2018
Completed a Series D funding round.
For institutional investors. Book with your work email.
U Star Biochemical Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about U Star Biochemical Technologies, Inc.'s valuation, stock price, and market status.
Is U Star Biochemical Technologies, Inc. a public or private company?
U Star Biochemical Technologies, Inc. is a private company.
What is the current stock price of U Star Biochemical Technologies, Inc.?
U Star Biochemical Technologies, Inc. is a private company, so its shares have no public market price. Caplight tracks U Star Biochemical Technologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is U Star Biochemical Technologies, Inc. worth (valuation)?
Valuation information for U Star Biochemical Technologies, Inc. is not publicly available.
Can I buy U Star Biochemical Technologies, Inc. stock?
U Star Biochemical Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was U Star Biochemical Technologies, Inc.'s last funding round?
U Star Biochemical Technologies, Inc.'s most recent funding round was Series E Extension on November 30, 2021.
Who are the main investors in U Star Biochemical Technologies, Inc.?
Key investors in U Star Biochemical Technologies, Inc. include Oriental Fortune Capital, CITIC Private Equity Funds Management.
Will U Star Biochemical Technologies, Inc. IPO soon?
No public IPO plans have been announced for U Star Biochemical Technologies, Inc..
How can I track U Star Biochemical Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in U Star Biochemical Technologies, Inc.'s shares on secondary markets.